MCTS1 and metastatic malignant neoplasm: Accordingly, the loss-of-function MCT-1 raises the chemo-sensitivity of cancer cells (Fig. 4), implying that targeting MCT-1 may enhance the therapeutic efficacy on advanced and metastatic cancer.